Back

Estimating individual cardiovascular disease risk reduction by blood pressure lowering in elderly patients: results from the HYVET study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hypertension - Risk profiling and treatment Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Tamar de Vries

University Medical Center Utrecht, Utrecht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Does blood pressure variability in normotensive individuals predict the development of hypertension?
Doctor H. Takase (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Mean blood pressures and visit to visit blood pressure variation as predictors of clinical outcomes in malignant hypertension: the west Birmingham malignant hypertension project.
Slides Video
Presentation thumbnail
Arterial hypertension after heart transplantation: prevalence, predictors and prognostic impact. Single centre prospective study
Professor A. Shevchenko (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Nt-proBNP combined with R wave in aVL lead predicts mortality better than echocardiographic left ventricular mass in hypertension
Assistant Professor P. Courand (Lyon, FR)
Abstract
Presentation thumbnail
Angiotensin converting enzyme inhibitor versus angiotensin receptor blockers on the top of calcium channel blocker in development of new-onset diabetes mellitus in hypertensive Korean patients
Professor Y. Kim (Chuncheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension - Risk profiling and treatment

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources